Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis

[1]  David N. Rider,et al.  Candidate Gene Analysis Using Imputed Genotypes: Cell Cycle Single-Nucleotide Polymorphisms and Ovarian Cancer Risk , 2009, Cancer Epidemiology Biomarkers & Prevention.

[2]  M. van Engeland,et al.  E2Fs mediate a fundamental cell‐cycle deregulation in high‐grade serous ovarian carcinomas , 2009, The Journal of pathology.

[3]  A. Whittemore,et al.  Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients. , 2008, European journal of cancer.

[4]  A. Whittemore,et al.  The Effects of Common Genetic Variants in Oncogenes on Ovarian Cancer Survival , 2008, Clinical Cancer Research.

[5]  A. Whittemore,et al.  Consortium analysis of 7 candidate SNPs for ovarian cancer , 2008, International journal of cancer.

[6]  R. Vierkant,et al.  Performance of Amplified DNA in an Illumina GoldenGate BeadArray Assay , 2008, Cancer Epidemiology Biomarkers & Prevention.

[7]  M. Pagano,et al.  Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer , 2008, Nature Reviews Cancer.

[8]  John D Potter,et al.  Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. , 2008, JAMA.

[9]  David N. Rider,et al.  Genetic variation in the one-carbon transfer pathway and ovarian cancer risk. , 2008, Cancer research.

[10]  Mark Liebow,et al.  Association of Single Nucleotide Polymorphisms in Glycosylation Genes with Risk of Epithelial Ovarian Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.

[11]  A. Whittemore,et al.  Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis , 2008, British Journal of Cancer.

[12]  Young Tae Kim,et al.  Alteration of cell-cycle regulation in epithelial ovarian cancer , 2007, International Journal of Gynecologic Cancer.

[13]  A. Whittemore,et al.  Association Between Single-Nucleotide Polymorphisms in Hormone Metabolism and DNA Repair Genes and Epithelial Ovarian Cancer: Results from Two Australian Studies and an Additional Validation Set , 2007, Cancer Epidemiology Biomarkers & Prevention.

[14]  B. Karlan,et al.  Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. , 2007, Gynecologic oncology.

[15]  Harlan M Krumholz,et al.  Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. , 2007, JAMA.

[16]  Francesmary Modugno,et al.  Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. , 2007, Cancer research.

[17]  J. Wang,et al.  Delayed activation of Bax by DNA damage in embryonic stem cells with knock-in mutations of the Abl nuclear localization signals , 2007, Cell Death and Differentiation.

[18]  Douglas F. Easton,et al.  Tagging Single Nucleotide Polymorphisms in the BRIP1 Gene and Susceptibility to Breast and Ovarian Cancer , 2007, PloS one.

[19]  Alison M Dunning,et al.  Association between Common Variation in 120 Candidate Genes and Breast Cancer Risk , 2007, PLoS genetics.

[20]  Leif E. Peterson,et al.  Characterization of BRCA1 and BRCA2 mutations in a large United States sample. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  J. Cools,et al.  Chronic myeloproliferative disorders: a tyrosine kinase tale , 2006, Leukemia.

[22]  A. Whittemore,et al.  Polymorphisms in DNA repair genes and epithelial ovarian cancer risk , 2005, International journal of cancer.

[23]  R. Vierkant,et al.  Estrogen Bioactivation, Genetic Polymorphisms, and Ovarian Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[24]  M. Heinrich,et al.  A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinib , 2005, Leukemia.

[25]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[26]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[27]  A. Giordano,et al.  Cell Cycle Genes in Ovarian Cancer , 2004, Clinical Cancer Research.

[28]  J. Juang,et al.  Abi Enhances Abl-Mediated Cdc2 Phosphorylation and Inactivation , 2004, Journal of Biomedical Science.

[29]  D. Gertig,et al.  Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  A. Whittemore,et al.  STK15 polymorphisms and association with risk of invasive ovarian cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[31]  Y. Hashiguchi,et al.  Alteration of cell cycle regulators correlates with survival in epithelial ovarian cancer patients. , 2004, Human pathology.

[32]  S. Riethdorf,et al.  Role of cell‐cycle regulatory proteins in gynecological cancer , 2003, Journal of cellular physiology.

[33]  Tony Hunter,et al.  Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases , 2003, Journal of Cell Science.

[34]  J. Bereiter-Hahn,et al.  Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1 , 2002, Oncogene.

[35]  J. Ioannidis,et al.  Replication validity of genetic association studies , 2001, Nature Genetics.

[36]  G. Superti-Furga,et al.  An intramolecular SH3-domain interaction regulates c-Abl activity , 1998, Nature Genetics.

[37]  A. Sood,et al.  The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis. , 1997, Cancer gene therapy.

[38]  M. Schwartz,et al.  Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Stephen J. Elledge,et al.  Cell Cycle Checkpoints: Preventing an Identity Crisis , 1996, Science.

[40]  W. G. Hill,et al.  Genetic Data Analysis II . By Bruce S. Weir, Sunderland, Massachusetts. Sinauer Associates, Inc.445 pages. ISBN 0-87893-902-4. , 1996 .

[41]  R. Weichselbaum,et al.  Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents , 1995, Nature.

[42]  P. J. Welch,et al.  A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle , 1993, Cell.

[43]  J. Wang,et al.  Abl tyrosine kinase in signal transduction and cell-cycle regulation. , 1993, Current opinion in genetics & development.

[44]  Bruce S. Weir,et al.  Genetic Data Analysis: Methods for Discrete Population Genetic Data. , 1991 .

[45]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[46]  R. Sutherland,et al.  Cell cycle machinery: links with genesis and treatment of breast cancer. , 2008, Advances in experimental medicine and biology.

[47]  C. Carlson,et al.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. , 2004, American journal of human genetics.

[48]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.